SB1317
SB1317 (TG02) is a multi-kinase inhibitor that potently targets CDKs, JAK2, and FLT3. It is a valuable research tool for studying oncology and hematological malignancies, with demonstrated activity in both in vitro cellular assays and in vivo preclinical models of cancer.
Product Specifications
CAS Number
1204918-72-8
Product Name Alternative
JAK2, JAK, FLT3, CDKs, CDK, TG02, TG-02, TG 02, SB1317, SB-1317, SB 1317
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Purity
99.86% (May vary between batches)
Solubility
DMSO:10 mM;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.37 mM)
Smiles
CN1C\C=C\CCOc2cccc (c2) C2=CC=N\C (N2) =N\c2cccc (C1) c2
Molecular Formula
C23H24N4O
Molecular Weight
372.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog